Christopher Paul Simms
Chief Commercial and Business Officer · 1 filing · Latest: Mar 25, 2026
4D Molecular Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Commercial and Business Officer · 1 filing · Latest: Mar 25, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|